Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD) was the target of a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 21,299 shares, an increase of 50.0% from the July 15th total of 14,197 shares. Approximately 0.3% of the company’s shares are sold short. Based on an average daily trading volume, of 36,032 shares, the days-to-cover ratio is currently 0.6 days.

Insider Buying and Selling at Ainos

In other news, major shareholder Carbon Nano Technology Taiwan sold 41,000 shares of the firm’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $2.36, for a total transaction of $96,760.00. Following the completion of the transaction, the insider owned 948,925 shares of the company’s stock, valued at approximately $2,239,463. This trade represents a 4.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ting-Chuan Lee sold 109,988 shares of Ainos stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $1.90, for a total transaction of $208,977.20. Following the transaction, the director owned 807,417 shares in the company, valued at approximately $1,534,092.30. This trade represents a 11.99% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders acquired 7,500 shares of company stock worth $15,435 and sold 179,788 shares worth $359,247. Corporate insiders own 9.79% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in AIMD. Two Sigma Investments LP acquired a new position in shares of Ainos during the third quarter valued at about $80,000. Renaissance Technologies LLC raised its holdings in shares of Ainos by 13.1% in the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after acquiring an additional 7,700 shares during the last quarter. DRW Securities LLC lifted its position in Ainos by 272.6% in the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock valued at $109,000 after acquiring an additional 48,439 shares in the last quarter. Finally, Mariner LLC bought a new position in Ainos in the 4th quarter valued at about $37,000.

Ainos Trading Up 5.7%

Shares of NASDAQ AIMD opened at $1.48 on Thursday. The firm’s 50-day moving average price is $1.67 and its 200-day moving average price is $1.70. The firm has a market capitalization of $10.92 million, a P/E ratio of -0.59 and a beta of 2.46. Ainos has a 1-year low of $1.26 and a 1-year high of $4.44.

Ainos (NASDAQ:AIMD) last released its quarterly earnings data on Monday, August 3rd. The company reported ($0.62) EPS for the quarter. Ainos had a negative net margin of 11,912.10% and a negative return on equity of 217.50%. The firm had revenue of $0.15 million for the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 26th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.